SCHEMBL1816640

SCHEMBL1816640

N#Cc1ccc(-c2ccc3c(c2)N(S(=O)(=O)c2ccc(N)nc2)CCO3)nc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 1/20 0.41
▸ PKLR P30613 1/20 0.41
▸ PIK3CA P42336 3/20 0.38
▸ CYP2C9 P11712 1/20 0.37
▸ CYP11B1 P15538 1/20 0.37
▸ CYP11B2 P19099 1/20 0.37
▸ RIPK2 O43353 1/20 0.36
▸ NOD2 Q9HC29 1/20 0.36
▸ SCN9A Q15858 4/20 0.36
▸ SCN5A Q14524 1/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ PDE3B Q13370 2/20 0.35
▸ PDE3A Q14432 2/20 0.35
▸ AKT1 P31749 2/20 0.35
▸ MTOR P42345 2/20 0.35
▸ CCR6 P51684 1/20 0.35
▸ MLNR O43193 1/20 0.35
▸ RORC P51449 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1819415 0.87 CYP2C9 (0.51) PKMPKLRCYP2C9CYP11B1CYP11B2
SCHEMBL1819876 0.87 CCNA2 (0.42) PKMPKLRCYP2C9CYP11B1CYP11B2
SCHEMBL12818616 0.84 PKM (0.40) PKMPKLRCYP2C9CYP11B1CYP11B2
SCHEMBL1818351 0.83 PIK3CA (0.39) PKMPKLRPIK3CACYP2C9RIPK2
SCHEMBL1818362 0.82 PIK3CA (0.40) PKMPKLRPIK3CACYP2C9RIPK2
SCHEMBL12818817 0.81 LMNA (0.40) PKMPKLRPIK3CACYP2C9MEN1
SCHEMBL1817818 0.79 CYP11B1 (0.45) PKMPKLRPIK3CACYP2C9CYP11B1
SCHEMBL1819495 0.79 PKM (0.44) PKMPKLRCYP2C9CYP11B1CYP11B2
SCHEMBL1821074 0.78 PKM (0.51) PKMPKLRCYP2C9CYP11B1CYP11B2
SCHEMBL1819438 0.77 NPC1 (0.44) PKMPKLRCYP2C9CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO claimed
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO disclosed
Send feedback